Michelle Rutta is a senior partner in White & Case's New York office and a member of the Securities Group and M&A Group, with over 30 years of experience in mergers and acquisitions, securities law, corporate governance, acquisition finance, high-yield debt and complex securities offerings.
Michelle chaired the Firm's Public Company Advisory Group and advises domestic and foreign companies on stock exchange, securities law compliance and disclosure matters and corporate governance issues. Clients also seek Michelle's advice in connection with M&A of public and private companies, spin-offs, leveraged buyouts and other acquisition transactions, as well as debt and equity securities and liability management transactions.
Michelle has represented companies in numerous acquisitions and acquisition financings in the healthcare industry, including Omnicare, Inc. in financing its acquisition of NCS HealthCare, Inc., which included the first ever issuance of a contingent interest, contingent convertible trust preferred security.
Michelle has extensive experience in the retail industry, having represented the underwriters in numerous financings for CVS Health Corporation, Reebok International Ltd., Phillips-Van Heusen Corporation and JC Penney Company. Michelle has also represented The Walt Disney Company in multiple financings, including Disney's first ever Canadian dollar-denominated security and first ever Luxembourg-listed security.
Michelle is listed as a Leading Individual for Corporate Governance in the US, Euromoney's Banking Finance and Transactional Expert Guide, 2020 and for Corporate/M&A in the US, Euromoney's Women in Business Law, 2020.
Michelle received her BA from City University of New York, Queens College (summa cum laude) and her JD from New York University School of Law (Editor, Moot Court Board).
Recent matters include the representation of:
- Lantheus Holdings, Inc. (NASDAQ: LNTH), developer of diagnostic imaging products, in the acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC), an oncology company.
- EchoStar Corporation (NASDAQ: SATS) in the tax-free spin-off and merger of its broadcast satellite service business, including nine satellites and certain real estate owned by EchoStar, with a subsidiary of DISH Network Corp. (NASDAQ: DISH).
- LifePoint Health, Inc., (NASDAQ: LPNT) in its US$5.6 billion sale of the company to RCCH HealthCare Partners, owned by funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO).
- ETF Securities Ltd.'s sale of its European commodities exchange traded fund business to Wisdom Tree Investments (NASDAQ: WETF) in a US$611 million cash and stock transaction.
- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a world leader in musculoskeletal health solutions, in its US$13.35 billion deal to acquire Biomet, Inc., a leading medical device manufacturer.
- The Walt Disney Company (NYSE: DIS) in its offering and sale of US$500 million 2.125% Notes due 2022 and listed on the Luxembourg Stock Exchange.
- Macquarie Infrastructure Corporation (NYSE: MIC) in financing its US$1.025 billion acquisition of the remaining interest in International-Matex Tank Terminals, the fuel storage terminal company.
- Omnicare, Inc. in its US$12.7 billion merger with a subsidiary of CVS Health Corporation.
- Special Committee of the Board of GFI Group Inc., (NYSE: GFIG), the brokerage and clearing house, in the tender offer by BGC Partners, Inc. (NASDAQ: BGCP) for the outstanding shares of GFI.